Bellete Ambaw
SEC insider (Form 3/4/5 filer). CIK 0002007090. President and COO at CG Oncology, Inc. (CGON). 3 reported Form 4/5 transactions since Sep 2024; latest on Apr 15, 2026. Located in DALLAS, TX.
Companies Bellete Ambaw has filed insider reports for
- CG Oncology, Inc. (CGON): Officer, President and COO
Bellete Ambaw
CIK: 0002007090
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CGON
CG Oncology, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Apr 15, 2026CGON
CG Oncology, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
107.5K shares- - Apr 15, 2025CGON
CG Oncology, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
284.8K shares- - Oct 4, 2024CGON
CG Oncology, Inc.
AwardDirectStock Option (Right to Buy)
175.5K shares-
1-3 of 3 transactions